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Conclusions: These unexpected ﬁndings show that a large dose of n-3 LC-
PUFA once per week is more effective in increasing whole body n-3 LC-
PUFA content compared with a smaller dose delivered daily.
Funding source(s): The Molecular Medicine Strategic Research Centre,
Deakin University.
SATURATED FAT ENHANCES INCORPORATION OF N-3
POLYUNSATURATED FATTY ACIDS INTO PLASMA AND ERYTHROCYTE
LIPIDS IN HEALTHY HUMANS
C.B. Dias 1,2, L.G. Wood 2, M.L. Garg 1,2. 1Nutraceuticals Research Group,
University of Newcastle, NSW, Australia; 2 School of Biomedical Sciences &
Pharmacy, University of Newcastle, NSW, Australia
E-mail address: cintia.dias@uon.edu.au (C.B. Dias)
Background/Aims: High fat meals have been previously shown to pro-
mote bioavailability of n-3 polyunsaturated fatty acids (n-3PUFA). While
the effect of dietary fat types on incorporation of n-3PUFA into blood and
tissue lipids has been widely discussed in the literature, to-date this
phenomenon has not been reported in humans.
Methods: This was a randomised, controlled, parallel, dietary interven-
tion trial involving 25 healthy adults aged 18 to 65 years. Subjects
consumed foods rich in either saturated (SFA) or n-6 polyunsaturated
fatty acids (n-6PUFA), all supplemented with 2.4 g n-3PUFA daily for 6
weeks. Blood samples were collected after an overnight fast, at baseline
and post-intervention, for analysis of plasma and red blood cell fatty
acids.
Results: Linoleic acid increased signiﬁcantly in plasma but not erythro-
cytes following the n-6PUFA diet, and did not change after the SFA diet.
There was an increase in eicosapentaenoic acid (EPA) which was signiﬁ-
cantly higher (2 fold) after the SFA compared to the n-6PUFA diet. There
was also a greater increase in docosahexaenoic acid (DHA) after the SFA
diet, although this was not signiﬁcantly different to the n-6PUFA diet.
Conversely there was a signiﬁcant reduction in plasma docosapentaenoic
acid (DPA) which was 2 fold greater following the n-6PUFA compared to
the SFA diet.
Conclusions: Dietary background fat type affects n-3PUFA incorporation
into plasma and erythrocytes in healthy subjects. Dietary SFA facilitate n-
3PUFA incorporation into plasma and erythrocytes compared to dietary n-
6PUFA.
Funding source(s): Hunter Medical Research Institute (HMRI) and Coor-
denaç~ao Nacional de Desenvolvimento Cientíﬁco e Tecnologico (CNPq,
Brazil).THE EFFECT OF LONG CHAIN OMEGA 3 PUFA ON RESTING AND
RECOVERY HEART RATE IN HEALTHY ADULTS
B. Isip, E. Neale, G. Peoples, L. Tapsell. University of Wollongong, NSW,
Australia
E-mail address: bi983@uowmail.edu.au (B. Isip)
Background/Aims: An elevated heart rate at rest and slower recovery
following exercise are indicators of cardiovascular disease (CVD) mortality
and death. Research suggests consumption of long chain omega-3 poly-
unsaturated fatty acids (LCn-3PUFA) have an anti-arrhythmic effect on the
heart and reduce heart rate in those with cardiovascular dysfunction. This
systematic literature review aimed to investigate the current evidence
regarding the effects of LCn-3PUFA on resting and recovery heart rate in
adults free from CVD.
Methods: A systematic search of the databases Scopus, Web of Science
and the Cochrane Library was conducted (January 2005 to May 2015).
Inclusion criteria were: randomised controlled trials investigating the
effect of LCn-3PUFA consumption on resting and/or recovery heart rate in
healthy adults without pre-existing CVD. Studies were assessed for
quality using the American Dietetic Association Quality Criteria
Checklist.
Results: Of the eight articles identiﬁed in this review, only two showed a
heart rate lowering effect of LCn-3PUFA consumption. These two studiesinvolved participants with elevated resting heart rates or risk factors for
CVD. Recovery heart rate was assessed in only one study, which found a
reduction following LCn-3PUFA consumption.
Conclusions:Whilst a lack of an effect of LCn-3PUFA on resting heart rate
was found in most studies, supplementation with LCn-3PUFA appeared to
be effective in individuals with elevated resting heart rates. Further studies
are needed to determine these effects on heart rate recovery in healthy
adults.
Funding source(s): N/A.
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Background/Aims: Analysis of the Sydney Heart Study reported an
adverse effect of dietary n-6 polyunsaturated fatty acids (PUFA) on mor-
tality, and recent meta-analyses have reached contrasting conclusions
regarding the effect of dietary n-6 polyunsaturated fatty acids (PUFA) on
cardiovascular mortality. The aim of this study was to examine the effect of
n-6 PUFA on mortality in the Australian Diabetes, Obesity and Lifestyle
Study (AusDiab) cohort, a large Australian prospective study of cardio-
metabolic health.
Methods: The relationship between dietary PUFA intake and all-cause or
CVD mortality in the AusDiab cohort, a population of 11,247 Australians
aged 25 y recruited in 1999/2000 and followed until 2012, was examined
using Cox regression. Comorbidities, demographic, and lifestyle informa-
tion was collected by questionnaire, and fasting blood tests undertaken.
Baseline dietary intake was assessed by a 121-item food frequency ques-
tionnaire. Vital status and causes of death were collected by linkage to
death registries.
Results: Adjusted for age and sex, those in the highest quintile of n-6 PUFA
intake had lower risk of total and cardiovascular mortality (all-cause
mortality HR: 0.82, 95% CI: 0.69-0.99, p <0.05), but this failed to retain
signiﬁcance after further adjustment for previous cardiovascular disease,
education, exercise, diabetes, dietary energy and smoking.
Conclusions: These ﬁndings from a contemporary Australian cohort sug-
gest that n-6 PUFA have neutral or possibly beneﬁcial effects on all-cause
and cardiovascular mortality.
Funding source(s): None to declare for these analyses. However AusDiab
has been funded by NHMRC, as well as support from State governments,
academic and industry bodies.
CONCURRENT SESSION 3: CARBOHYDRATES.
THE EFFECT OF IMPROVING DIETARY QUALITY ON MEASURES OF
VASCULAR STRUCTURE AND FUNCTION IN A POPULATION WITH
DIABETES
K.S. Petersen, J.B. Keogh, N. Blanch, P.M. Clifton. School of Pharmacy and
Medical Sciences, University of South Australia, SA, Australia
E-mail address: kristina.petersen@mymail.unisa.edu.au (K.S. Petersen)
Background/Aims: People with diabetes have a heightened risk of
cardiovascular disease compared with the general population. The aim
was to determine if increasing fruit (+1 serving), vegetable (+2 servings)
and dairy (+1 serving) intake slows 12 month common carotid artery
intima media thickness (CCA-IMT) progression, compared to a control
group continuing on their usual diet, in people with type 1 and type 2
diabetes. Secondary outcome measures were peripheral and central
blood pressure, augmentation index (AI) and pulse wave velocity
(PWV).
Methods: A 12 month randomised controlled trial was conducted. The
primary outcome was mean CCA-IMT, measured at baseline and 12
months using B mode ultrasound. Secondary outcomes were peripheral
and central blood pressure, AI and PWV, measured at baseline, 3, 6, 9 and
12 months. Participants in the intervention group received dietary
